PREGNOLATO, FRANCESCA
PREGNOLATO, FRANCESCA
Dipartimento di Scienze Cliniche e di Comunità
Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients
2022 T. Schioppo, L.M. Argolini, S. Sciascia, F. Pregnolato, F. Tamborini, P. Miraglia, D. Roccatello, R.A. Sinico, R. Caporali, G. Moroni, M. Gerosa
Pregnancy in juvenile idiopathic arthritis: maternal and foetal outcome, and impact on disease activity
2022 M. Gerosa, C.B. Chighizola, F. Pregnolato, I. Pontikaki, A.F. Luppino, L. Maria Argolini, L. Trespidi, M. Wally Ossola, E.M. Ferrazzi, R. Caporali, R. Cimaz
Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers
2022 M.O. Borghi, M. Bombaci, C. Bodio, P.A. Lonati, A. Gobbini, M. Lorenzo, E. Torresani, A. Dubini, I. Bulgarelli, F. Solari, F. Pregnolato, A. Bandera, A. Gori, G. Parati, S. Abrignani, R. Grifantini, P.L. Meroni
Hyaluronic Acid Therapy in Hip OA Does Not Perform Equally in Osteoarthritis Secondary to Juvenile Idiopathic Arthritis When Compared to Primary Osteoarthritis: A 2-Year Preliminary Evaluation
2022 O. DE LUCIA, A.F. Luppino, F. Pregnolato, A. Murgo, I. Pontikaki, M. Gattinara, T. Ubiali, R. Cimaz, R.F. Caporali
Genetic Variants and Therapeutic Response to Anti-TNF-α Agents in Juvenile Idiopathic Arthritis: An Updated Systematic Review and Meta-analysis
2022 F. Pregnolato, C.B. Chighizola, T. Giani, S. Costi, A. Marino, R. Cimaz
Comment on: EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies: Reply
2021 C.B. Chighizola, F. Pregnolato
EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies
2021 F. Pregnolato, M. Gerosa, M.G. Raimondo, C. Comerio, F. Bartoli, P.A. Lonati, M.O. Borghi, B. Acaia, M.W. Ossola, E. Ferrazzi, L. Trespidi, P.L. Meroni, C.B. Chighizola
Psychosocial burden in young patients with primary anti-phospholipid syndrome: an Italian nationwide survey (The AQUEOUS study)
2021 C. Chighizola, F. Crisafulli, A. Hoxha, F. Carubbi, M. Bellan, S. Monti, L. Costa, C. Baldi, M. Radin, E. Praino, L. Coletto, F. Pregnolato, S. Sciascia, P. Sainaghi, E. Bellis, V. Ramoni, L. Quartuccio, A. Alunno, M. Gerosa, L. Andreoli
In utero exposure to Azathioprine in autoimmune disease. Where do we stand?
2020 C. Belizna, P.L. Meroni, Y. Shoenfeld, K. Devreese, J. Alijotas-Reig, E. Esteve-Valverde, C. Chighizola, F. Pregnolato, H. Cohen, C. Fassot, P.M. Mattera, P. Peretti, A. Levy, L. Bernard, M. Saiet, L. Lagarce, M. Briet, M. Rivière, I. Pellier, G. Gascoin, J. Rakotonjanahary, M.O. Borghi, L. Stojanovich, A. Djokovic, N. Stanisavljevic, R. Bromley, E. Elefant-Amoura, N. Bahi Buisson, T. Pindi Sala, H. Kelchtermans, A. Makatsariya, V. Bidsatze, J. Khizroeva, J.O. Latino, S. Udry, D. Henrion, L. Loufrani, A.L. Guihot, C. Muchardt, M. Hasan, M.N. Ungeheuer, J. Voswinkel, L. Damian, I. Pabinger, J. Gebhart, R. Lopez Pedrera, J.W. Cohen Tervaert, A. Tincani, L. Andreoli